FdaApplication

NDA 021110

Back to search

Identifiers

Properties

PropertyValue
applicant_namePF PRISM CV
application_typeNDA
approval_date2000-08-25

Products (4)

ProductActive ingredientStrengthDosage form
RAPAMUNESIROLIMUS1MGTABLET;ORAL
RAPAMUNESIROLIMUS2MGTABLET;ORAL
RAPAMUNESIROLIMUS0.5MGTABLET;ORAL
RAPAMUNESIROLIMUS5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL

4 products